SCHEMBL3373458

SCHEMBL3373458

CC(C)(C)OC(=O)N1CCC(Oc2ccc(COc3ccc(-n4cnnn4)cc3F)cc2)CC1

nearest known ligand 0.56

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 11/20 0.56
SMN1; SMN2 Q16637 1/20 0.46
MAPT P10636 2/20 0.44
TP53 P04637 1/20 0.44
CHEK2 O96017 1/20 0.43
PDE4D Q08499 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3372317 0.84 GPR119 (0.50) GPR119SMN1; SMN2MAPTTP53CHEK2
SCHEMBL11309424 0.83 GPR119 (0.55) GPR119
SCHEMBL3767188 0.83 GPR119 (0.55) GPR119
SCHEMBL3372121 0.81 GPR119 (0.58) GPR119SMN1; SMN2MAPTCHEK2
SCHEMBL3373756 0.81 GPR119 (0.51) GPR119
SCHEMBL3762480 0.80 GPR119 (0.59) GPR119
SCHEMBL10325161 0.80 GPR119 (0.60) GPR119
SCHEMBL4284717 0.80 GPR119 (0.58) GPR119
SCHEMBL1557229 0.80 GPR119 (0.60) GPR119
SCHEMBL3490335 0.79 GPR119 (0.61) GPR119SMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010048149-A2 HETEROCYCLIC MODULATORS OF GPR119 FOR TREATMENT OF DISEASE KALYPSYS, INC. (US) 2010-04-29 WO disclosed
WO-2010048149-A2 HETEROCYCLIC MODULATORS OF GPR119 FOR TREATMENT OF DISEASE KALYPSYS, INC. (US) 2010-04-29 WO disclosed